Research & Development: Page 87

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Success Beyond the Silos

    By Robin Robinson Forum Innovative pharmaceutical companies are redefining the communications process by tearing down the walls between the different factions: agencies, sales, marketing, and public relations. More and more pharmaceutical companies are breaking out of their siloed structure to re...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Marketplace

    Featured Product and Service Showcases AmerisourceBergen Specialty Group Axis Healthcare Communications LLC Cadent Medical Communications The Center for Biomedical Continuing Education CME LLC cme2 The Curry Rockefeller Group LLC Excerpta Medica Innovia Education Institute LLC Institu...

    By PharmaVoice Team • Jan. 2, 2008
  • digital pill Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Artificial intelligence & machine learning

    After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The State of CME

    August 2007 VIEW on Medical Education The State of CME by Kate Guerriero Continuing medical education could be argued to be one of the most ever-changing fundamentals in the healthcare industry today. Ensuring that CME remains in compliance ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    With so much negative press these days surrounding the pharmaceutical and life-sciences industries, it is our pleasure to once again be able to relate the positive aspects of our industry. We want to thank the thousands of individuals who took the time to send in their thoughtful write ups as par...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Patient Advocates

    With an unwavering commitment to patients and protecting their rights, these forward-thinking individuals are advocating best practices for clinical-trial recruitment and education. Zane Wilson Speaking up for Those in Need Despite an often uphill battle to provide better facilities for patients ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Researchers & Scientists

    Matthew Coffey, Ph.D. Barry Eisenstein, M.D. Robert Lanza, M.D. Christine Smith Ana Szarfman, M.D., Ph.D. From discovery through clinical development, the researchers and scientists behind the medicines are making a significant impact on the pipelines of today and of the future. Current positions...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Technologists

    These innovators of technology-based solutions are improving connections across silos to facilitate the drug-development process and customer interactions. PharmaVOICE 100 July/August 2007 Vikas Vats The Sky’s the limit for innovation Current position VP, marketRx Place and date of Birth New Delh...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Inverting the Enrollment Trend of Clinical Trials

    Inverting the Enrollment Trend of Clinical Trials One of the largest challenges facing the industry today is inverting the trend of clinical trials failing to complete enrollment on time. Raising awareness of a particular clinical trial with call-to-action advertising, such as broadcast televi...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Guidance and Technology: A Single-Source Solution

    Guidance and Technology: A Single-Source Solution Rick Piazza, VP, Product Strategy In today’s technology-reliant clinical-trial studies, it is crucial that software providers maintain a staff of in-house experts to offer counsel and guidance to sponsors. These experts act as process partne...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    New Techniques Drive Patient Enrollment for Trials

    New Techniques Drive Patient Enrollment for Trials The number of clinical trials for new drugs continues to grow, increasing the competition for patients. IMS data show that new drug-discovery technologies are fueling record worldwide growth. There are more than 13,000 studies projected for 20...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Clinical Services: Managing the Moving Parts

    Clinical Services: Managing the Moving Parts By Taren Grom, Editor The Cost of Doing Business The cost of drug development remains on the rise, with most estimates showing that the clinical-trials stage alone accounts for 40% of all costs related to R&D. Our Forum experts discuss...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    Letter from the Editor The Forum Clinical Services: Managing the Moving Parts — The clinical-research process is complex and requires integrated, sophisticated processes, technologies, and management to reduce costs, improve timelines, and produce safe therapeutics. Company Listing by Topic of In...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Integration and Workflow Issues for Clinical-Services Providers to Ensure Smooth Trials

    Integration and Workflow Issues for Clinical-Services Providers to Ensure Smooth Trials Mary T. Stefanzick, Associate Director of Operations An ongoing imperative in clinical research for pharma and biotech companies is to accelerate processes and timelines to get new products to market ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Overcoming Poor Quality Data for ECG Collection

    Overcoming Poor Quality Data for ECG Collection Timothy Callahan, Ph.D., Chief Scientific Officer The ICH E14 has become the touchstone guideline when designing and implementing Thorough QT (TQT) trials. Even protocols that are not designed primarily as a QT trial often use recommendations fr...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Using Advanced Simulation in Clinical Operations

    Using Advanced Simulation in Clinical Operations Jack Porter, President and CEO, ePharmamindshare The introduction of supercomputers and sophisticated simulation software for planning and optimizing clinical trials is rapidly becoming established in the pharmaceutical industry. These simulati...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Benefits of Using an EDC System to Collect and Reconcile Serious Adverse Events

    Benefits of Using an EDC System to Collect and Reconcile Serious Adverse Events Gary Tyson, Senior VP, Clinical Development Practice Marybeth Lynch, Associate Practice Executive, Clinical Development Practice Collecting and reconciling adverse events (AEs) and serious adverse events (SAEs)...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pediatric Patient Retention: It's not Child's Play

    Pediatric Patient Retention: It’s not Child’s Play Elizabeth Moench President and CEO Samantha Cook Pediatric Account Manager John Hartigan VP, Creative and Editorial Services The Ever-Changing Population A universal challenge of conducting long-term pediatric studies is the constant ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The ROI of ePRO

    The ROI of ePRO Phil Lee, President and CEO The power of listening to the patient voice by using e-diary systems to collect the best PRO data possible and manage subject enrollment, compliance, and safety in real time may still be overlooked by some sponsors, who are hesitant to switch to eP...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    rug development is a lengthy, complex, and expensive process, requiring hundreds of moving parts to act in concert to bring a therapeutic agent safely to market. According to the Association of Clinical Research Organizations, bringing a new drug or medical device to market can take 20 years an...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Solutions and Services: The Wider Landscape

    Pharma Solutions and Services: The Wider Landscape by Jeffrey Smith, Managing Director Given the central role of pharmaceuticals in the single largest U.S. economic sector, and the extent to which the pharma industry is information-driven, the already very act...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Clinical Resource Management: New Strategy Minimizes Co-Employment Risk

    Clinical Resource Management: New Strategy Minimizes Co-Employment Risk inVentiv Clinical Solutions LLC The approval of a new drug candidate is typically impacted by hundreds, if not thousands, of people during the development cycle. Without talented people, the clinical development plan is...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    An Emissary for Patients -- Kathy Giusti

    An Emissary for Patients — Kathy Giusti Nonprofit and successful business are terms seldom spoken together, yet demonstrably this is the way to achieve results. Make no mistake, uniting these two concepts takes a truly special individual. Kathy Giusti, founder and CEO of the Multiple Myeloma Rese...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    ACRO’s Chair Jeffrey McMullen In December 2006, Jeffrey McMullen, president and CEO of PharmaNet Development Group, was elected chair of the Association of Clinical Research Organizations (ACRO), Washington, D.C. (For more information about ACRO, visit acrohealth.org.) He is joined on the board b...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    ACRP conference Record Attendance The 2007 ACRP Global Conference and Exposition in Seattle drew more than 2,700 attendees, making this year’s event one of the most successful for the organization. The association is positioned as the primary resource for clinical research professionals in the ph...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Managed Markets: Pharmacists

    Playing a Pivotal Role Experts believe that pharmacists are ideally positioned to help patients better manage their drug therapies, as such they play a pivotal role helping seniors navigate the new Medicare Part D prescription drug plan. By Denise Myshko Pharmacists across the United States conti...

    By Denise Myshko • Jan. 2, 2008